Crestchem Ltd

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Hold to Sell as of 16 July 2026. The revision primarily stems from a shift in valuation metrics, despite the company’s robust financial performance and operational efficiency. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this change in rating.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid robust financial metrics and a challenging peer landscape, prompting a reassessment of its price attractiveness relative to historical and sector benchmarks.

Crestchem Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change is underpinned by a significant improvement in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to both its historical averages and peer group, signalling a potential opportunity for investors seeking value in a challenging market environment.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 25 June 2026. This change reflects a marked improvement in valuation metrics, sustained financial performance, and a balanced technical outlook, despite recent stock price volatility. The upgrade comes amid a backdrop of strong return on equity and operating profit growth, positioning Crestchem as a more compelling option within its peer group.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has seen its investment rating downgraded from Hold to Sell as of 15 June 2026. This change reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite some positive financial results and strong long-term returns, the stock’s recent underperformance and evolving technical signals have prompted a more cautious stance.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Sell to Hold as of 10 June 2026. This change reflects a combination of improved technical indicators, attractive valuation metrics, stable financial trends, and a solid quality profile, signalling a cautious but positive outlook for investors.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed sector performance and evolving market sentiment, with the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now signalling improved price attractiveness relative to its historical averages and peer group.

The 50-day moving average for Crestchem Ltd has crossed above the 200-day moving average, signalling a golden cross on 10 Jun 2026. Yet, this technical event coincides with a 4.32% decline in the stock price on the same day and a bearish monthly momentum backdrop, raising questions about the signal’s reliability in this micro-cap specialty chemicals firm.

Crestchem Ltd, a micro-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This change reflects evolving market perceptions amid a strong price rally, with the stock outperforming the Sensex significantly over recent periods. Despite a modest upgrade in valuation grades, the company retains a Sell mojo grade, underscoring ongoing caution among analysts.

Crestchem Ltd., a Gujarat-based specialty chemicals manufacturer, reported a stellar performance for the quarter ended March 2026, posting net profit of ₹1.10 crores on revenues of ₹10.23 crores. However, the quarterly strength stands in stark contrast to the company's full-year performance, which saw revenues decline 19.0% year-on-year to ₹25.00 crores in FY25, raising questions about sustainability. The micro-cap stock, currently trading at ₹124.00 with a market capitalisation of ₹36.00 crores, has delivered a disappointing -31.87% return over the past year, significantly underperforming both the broader market and its specialty chemicals peer group.

Crestchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 May 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Crestchem Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 15 May 2026. This change is primarily driven by a significant improvement in valuation metrics, despite flat financial performance and underwhelming returns over the past year. The upgrade reflects a nuanced assessment across quality, valuation, financial trends, and technical factors, signalling cautious optimism amid ongoing challenges.